PulseMedica
Building revolutionary technology to image and treat vitreoretinal disease.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
* | CAD12.0m | Early VC | |
| Total Funding | 000k | ||
Related Content
PulseMedica, an Edmonton-based medical device startup, is on a mission to improve the quality of life for millions of people by building revolutionary technology to image and treat vitreoretinal disease. They are creating an ophthalmic medical device platform for non-invasive, automated image-guided laser treatment, leveraging breakthroughs in 3D computer vision, real-time tracking and femtosecond laser technology. PulseMedica’s short-term vision is to become the global expert in safe, effective, non-invasive, screening and treatment of eye floaters, with the ultimate vision of becoming the global standard for screening and treating vitreoretinal disease.